Institutional Review Board Statement
This study received the approval of the Cochin–CPP Ile de France IV (Paris) Ethics Committee and of the French National Agency for Medicines and Health Products Safety (ANSM) (Ile de Frasnce IV), Clinical Trials Number NCT03859882, and was conducted according to the principles expressed in the Declaration of Helsinki of 1975, as revised in 2001.